Clinical and market positioning of project for application of clinical trials in gastrointestinal indications
| Reference number | |
| Coordinator | Ilya Pharma AB |
| Funding from Vinnova | SEK 500 000 |
| Project duration | July 2021 - October 2021 |
| Status | Completed |
| Venture | Preparation projects for international application within health |
| Call | Preparation projects for international application within health 2021 |
Important results from the project
** Denna text är maskinöversatt ** Aim: The proposed project aims to improve the positioning for an international grant application with significant funds Objective: -Quantify medical needs, pipeline and market in two medical indications -Develop a synopsis first with experts for a trial
Expected long term effects
** Denna text är maskinöversatt ** Medical need, pipeline and market have been defined in two medical indications for the company´s other drug candidate ILP100-Oral. One of the indications has been selected for the clinical development program and a synopsis for a first clinical trial has been prepared together with relevant medical experts. The data has been used in project proposals for two international calls with significant scope.
Approach and implementation
** Denna text är maskinöversatt ** The work has been carried out with internal and external resources, all work packages have been carried out according to plan.